Subscribe to RSS
DOI: 10.1055/s-2005-837759
In vitro Protein Tyrosine Phosphatase 1B Inhibitory Phenols from the Seeds of Psoralea corylifolia
Publication History
Received: June 23, 2004
Accepted: October 14, 2004
Publication Date:
27 January 2005 (online)
Abstract
Protein tyrosine phosphatase 1B plays a major role in the negative regulation of insulin signaling, and this establishes protein tyrosine phosphatase 1B as an attractive therapeutic target for diabetes. Bioassay-guided fractionation of the EtOAc-soluble extract of the seeds of Psoralea corylifolia afforded two protein tyrosine phosphatase 1B inhibitory compounds, psoralidin (1) and bakuchiol (2), along with inactive corylin. Compounds 1 and 2 inhibited PTP1B activity in a dose-dependent manner, displaying IC50 values of 9.4 ± 0.5 μM and 20.8 ± 1.9 μM, respectively.
References
- 1 Moller D E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 2001; 414 821-7
- 2 van Huijsduijnen R H, Bombrun A, Swinnen D. Selecting protein tyrosine phosphatases as drug targets. Drug Discov Today. 2002; 7 1013-9
- 3 Johnson T O, Ermolieff J, Jirousek M R. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov. 2002; 1 696-709
- 4 Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser M J, Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. 1997; 272 843-51
- 5 Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y. Insulin-like effects of vanadium: basic and clinical implications. J Inorg Biochem. 2000; 80 21-5
- 6 Imparl-Radosevich J, Deas S, Polansky M M, Baedke D A, Ingebritsen T S, Anderson R A, Graves D J. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998; 50 177-82
- 7 Chen R M, Hu L H, An T Y, Li J, Shen Q. Natural PTP1B inhibitors from Broussonetia papyrifera . Bioorg Med Chem Lett. 2002; 12 3387-90
- 8 Zhu Y P. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Amsterdam; Harwood Academic Publishers 1998: pp 609-12
- 9 Yang Y M, Hyun J W, Sung M S, Chung H S, Kim B K, Paik W H, Kang S S, Park J G. The cytotoxicity of psoralidin from Psoralea corylifolia . Planta Med. 1996; 62 353-4
- 10 Cho H, Jun J Y, Song E K, Kang K H, Baek H Y, Ko Y S, Kim Y C. Bakuchiol: a hepatoprotective compound of Psoralea corylifolia on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med. 2001; 67 750-1
- 11 Wang D, Li F, Jiang Z. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med. 2001; 67 748-9
- 12 Xiong Z, Wang D, Xu Y, Li F. Osteoblastic differentiation bioassay and its application to investigating the activity of fractions and compounds from Psoralea corylifolia L. Pharmazie. 2003; 58 925-8
- 13 Khatune N A, Islam M E, Haque M E, Khondkar P, Rahman M M. Antibacterial compounds from the seeds of Psoralea corylifolia . Fitoterapia. 2004; 75 228-30
- 14 Hamaguchi T, Sudo T, Osada H. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Letters. 1995; 372 54-8
- 15 Iwamura J, Dohi T, Tanaka H, Odani T, Kubo M. Cytotoxicity of corylifoliae fructus. II. Cytotoxicity of bakuchiol and the analogues. Yakugaku Zasshi. 1989; 109 962-5
- 16 Lee M S, Oh W K, Kim B Y, Ahn S C, Kang D O, Sohn C B, Osada H, Ahn J S. Inhibition of VHR dual-specificity protein tyrosine phosphatase activity by flavonoids isolated from Scutellaria baicalensis: structure-activity relationships. Planta Med. 2002; 68 1063-5
Dr. Jong Seog Ahn
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
52 Eoeun-dong
Yusong
Daejeon 305-333
Korea
Fax: +82-42-860-4595
Email: jsahn@kribb.re.kr